OCPNF

Healthcare Medical Devices

Olympus Corporation

$12.13
+0.00 +0.00% today

Price History

Not enough data

Key Stats

Market Cap
12.89B
Avg Volume
666
P/E (TTM)
29.59
EPS
$0.41
52W High
$14.00
52W Low
$8.00
Div. Yield
247.3%

Valuation

P/B Ratio
2.72
P/S Ratio
0.01
EV/EBITDA
0.97
EV/Revenue
0.20
PEG Ratio
3.16

Margins

Gross Margin 64.7%
Operating Margin 12.5%
Net Margin 7.5%
EBITDA Margin 20.9%

Growth & Returns

Revenue Growth (YoY)
16.4%
Earnings Growth (YoY)
122.6%
Earnings Growth (QoQ)
112.5%
Return on Equity
10.6%
Return on Assets
6.3%

Liquidity & Leverage

Current Ratio
1.36
Quick Ratio
0.72
Debt / Equity
0.43
Total Cash
118.54B
Total Debt
318.89B

About

Olympus Corporation, together with its subsidiaries, engages in the manufacture and sale of medical equipment in Japan, America, the Middle East, Asia, and Oceania. It operates through two segments, “Gastrointestinal Solutions and Surgical & Interventional Solutions. The company offers gastrointestinal Solutions products offer gastrointestinal endoscopes, gastroenterology devices, and medical services. The Surgical & Interventional Solutions provides urology, respiratory, surgical endoscopes, energy devices, ENT products, and gynecology products. It also provides respiratory products comprising bronchoscopy systems and devices, lung cancer products, and chronic obstructive pulmonary disease products; urology products consisting of visualization, stone management, benign prostatic hyperplasia (BPH), and BPH + bladder cancer products; surgical products, such as surgical endoscopy systems, advanced energy devices, surgical microscope, integrated procedure room solutions, and rhino-laryngoscopy systems, as well as surgical devices for the ears, nose, and throat. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was incorporated in 1919 and is headquartered in Hachioji, Japan.

www.olympus.co.jp